Made available in DSpace on 2014-12-17T14:13:22Z (GMT). No. of bitstreams: 1 GiuseppeAP.pdf: 289778 bytes, checksum: 0019c3f931b948d4ac6b9aa32d20ec37 (MD5) Previous issue date: 2007-08-16 / &#65279;The use of radionuclides has contributed for advances in Health Sciences, to research or to the diagnosis and/or treatment of diseases. These advances have been possible with the utilization of radiopharmaceuticals labeled with technetium-99m (99mTc). Stannous chloride (SnCl2) has the main reducing agent utilized to obtain radiopharmaceuticals labeled with technetium-99m. It has been reported that several natural or synthetic drugs are capable to alter the labeling of blood constituents with 99mTc, as well as the red blood cells morphology. The aim of this study was to evaluate possible alterations of Chrysobalanus icaco extract on the labeling of blood constituents with 99mTc, on the morphology of RBC of blood of Wistar rats, on the breakage of plasmid DNA and on the effects of stannous chloride on plasmid DNA. The results showed significant (P<0.05) alteration of the labeling of blood constituents with 99mTc, as well as, modification of the morphology and morphometry (perimeter/area ratio) of the RBC in presence of the extract. These data suggest that this abajeru extract could alter the labeling of blood constituents with 99mTc by its chelating/antioxidant action and/or effects on membrane structures. Moreover C. icaco extract altered the electrophoretic profile and decreased significantly (p<0.05) the effect of SnCl2 on plasmid DNA. The results obtained in this work could indicate a dose-dependent protective action against the SnCl2 and a genotoxic effect of C. icaco extract on plasmid DNA / &#65279;O uso de radionucl?deos tem contribu?do para avan?os relevantes em Ci?ncias da Sa?de, seja para pesquisa ou seja para o diagn?stico e/ou tratamento de doen?as. Muitos desses avan?os t?m sido poss?veis com a utiliza??o de radiof?rmacos marcados com tecn?cio-99m (99mTc). A marca??o desses radiof?rmacos necessita de um agente redutor e o cloreto estanoso tem sido o mais empregado. Tem sido descrito que diversas drogas naturais ou sint?ticas s?o capazes de interferir na marca??o de constituintes sangu?neos com 99mTc, assim como na morfologia das hem?cias. O objetivo deste estudo foi avaliar poss?veis interfer?ncias de um extrato de Chrysobalanus icaco (C. icaco) na marca??o dos constituintes sangu?neos com 99mTc, na morfologia de hem?cias do sangue de ratos Wistar, na quebra de DNA de plasm?dios e na a??o do cloreto estanoso no DNA plasmidial. Os resultados indicam que o extrato de C. icaco altera a marca??o de constituintes sangu?neos significativamente (p<0,05) com 99mTc, a morfologia e a morfometria (rela??o per?metro/?rea) das hem?cias, talvez por a??o quelante ou antioxidante e/ou por efeitos em estruturas da membrana envolvidas no transporte de ?ons. Al?m disso C. icaco altera o perfil eletrofor?tico e diminui significativamente (p<0.05) os efeitos do cloreto estanoso no DNA plasmidial. Estes ?ltimos resultados sugerem uma a??o protetora dose-dependente contra a a??o do cloreto estanoso e um efeito genot?xico do extrato de C. icaco no DNA plasmidial. O estudo tem car?ter multidisciplinar com a participa??o das seguintes ?reas do conhecimento: Radiobiologia, Bot?nica, Gen?tica, Fitoterapia e Hematologia